Immunoglobulin V regions and the B cell

Blood

Volumn 83, Issue 7, 1994, Pages 1717-1730

  Stewart, A Keith ^a   Schwartz, Robert S ^b  

^a TORONTO GENERAL HOSPITAL   (Canada)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN RECOGNITION; ANTIGEN SPECIFICITY; B LYMPHOCYTE; GENE REARRANGEMENT; HUMAN; IMMUNOGLOBULIN GENE; IMMUNOGLOBULIN VARIABLE REGION; PRIORITY JOURNAL; REVIEW;

EID: 0028217004     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v83.7.1717.1717     Document Type: Review

References (225)

1. Alt FW, Oltz EM, Young F, Gorman J, Taccioli G, Chen J: VDJ recombination. Immunol Today 13:306, 1992
2. Schatz DG, Oettinger MA, Schlissel MS: V(D)J recombination: Molecular biology and regulation. Annu Rev Immunol 10:359, 1992
3. Tonegawa S: Somatic generation of antibody diversity. Nature 302:575, 1983
4. Seidman JG, Leder P: The arrangement and rearrangement of antibody genes. Nature 276:790, 1978
5. Seidman JG, Leder A, Nau M, Norman B, Leder P: Antibody diversity. Science 202:11, 1978
6. Honjo T, Habu S: Origin of immune diversity: Genetic variation and selection. Annu Rev Biochem 54:803, 1985
7. Seidman JG, Nau MM, Norman B, Kwan SP, Scharff M, Leder P: Immunoglobulin V/J recombination is accompanied by deletion of joining site and variable region segments. Proc Natl Acad Sci USA 77:6022, 1980
8. Brack C, Hirama M, Lenhard S, Tonegawa S: A complete immunoglobulin gene is created by somatic recombination. Cell 15:1, 1978
9. Early P, Huang H, Davis M, Calame K, Hood L: An immunoglobulin heavy chain variable region gene is generated from three segments of DNA: VH, D and JH. Cell 19:981, 1980
10. Reth MG, Jackson S, Alt FW: VHDJH formation and DJH replacement during pre-B differentiation. EMBO J 5:2131, 1986
11. Lorenz W, Straubinger B, Zachau HG: Physical map of the human immunoglobulin κ locus and its implications for the mechanism of Vκ-Jκ rearrangement. Nucleic Acids Res 15:9667, 1987
12. Pohlenz HD, Straubinger B, Thiebe R, Pech M, Zimmer FJ, Zachau HG: The human V kappa locus. Characterization of extended immunoglobulin gene regions by cosmid cloning. J Mol Biol 193:241, 1987
13. Meindl A, Klobeck HG, Ohnheiser R, Zachau HG: The Vκ gene repertoire in the human germ line. Eur J Immunol 20:1855, 1990
14. Williams SC, Winter G: Cloning and sequencing of human immunoglobulin Vλ gene segments. Eur J Immunol 23:1456, 1993
15. Kirsch IR, Morton CC, Nakahara K, Leder P: Human immunoglobulin heavy chain genes map to a region of translocations in malignant B lymphocytes. Science 216:301, 1982
16. Berman JE, Mellis SJ, Pollock R, Smith CL, Suh H, Heinke B, Kowal C, Surti U, Chess L, Cantor CR: Content and organization of the human Ig VH locus: Definition of three new VH families and linkage to the Ig CH locus. EMBO J 7:727, 1988
17. Siebenlist U, Ravetch JV, Korsmeyer S, Waldmann T, Leder P: Human immunoglobulin D segments encoded in tandem multigenic families. Nature 294:631, 1981
18. Ichihara Y, Matsuoka H, Kurosawa Y: Organization of human immunoglobulin heavy chain diversity gene loci. EMBO J 7:4141, 1988
19. Ravetch JV, Siebenlist U, Korsmeyer S, Waldmann T, Leder P: Structure of the human immunoglobulin mu locus: Characterization of embryonic and rearranged J and D genes. Cell 27:583, 1981
20. Buluwela L, Albertson DG, Sherrington P, Rabbitts PH, Spurr N, Rabbitts TH: The use of chromosomal translocations to study human immunoglobulin gene organization: Mapping DH segments within 35 kb of the C mu gene and identification of a new DH locus. EMBO J 7:2003, 1988
21. Tomlinson IM, Walter G, Marks JD, Llewelyn MB, Winter G: The repertoire of human germline VH sequences reveals about fifty groups of VH segments with different hypervariable loops. J Mol Biol 227:776, 1992
22. Matsuda F, Shin EY, Nagaoka H, Matsumura R, Haino M, Fukita Y, Taka-ishi S, Imai T, Riley JH, Anand R, Soeda E, Honjo T: Structure and physical map of 64 variable segments in the 3́ 0.8-megabase region of the human immunoglobulin heavy-chain locus. Nature Genet 3:88, 1993
23. Kabat E, Wu TT, Perry HM, Gottesman KS, Foeller C: Sequences of Proteins of Immunologic Interest (ed 5). Bethesda, MD, US Department of Health and Human Services, 1991
24. Schroeder HW Jr, Hillson JL, Perlmutter RM: Structure and evolution of mammalian VH families. Int Immunol 2:41, 1990
25. Rechavi G, Ram D, Glazer L, Zakut R, Givol D: Evolutionary aspects of immunoglobulin heavy chain variable region (VH) subgroups. Proc Natl Acad Sci USA 80:855, 1983
26. Silver DP, Spanopoulo E, Mulligan RC, Baltimore D: Dispensable sequence motifs in the RAG 1 and RAG 2 genes for plasmid VDJ recombination. Proc Natl Acad Sci USA 90:6100, 1993
27. Yancopoulos GD, Blackwell TK, Suh H, Hood L, Alt FW: Introduced T cell receptor variable region gene segments recombine in pre B cells: Evidence that B and T cells use a common recombinase. Cell 44:251, 1986
28. Blackwell TK, Moore MW, Yancopoulos GD, Suh H, Lutzkev S, Selbing E, Alt FW: Recombination between immunoglobulin variable region gene segments is enhanced by transcription. Nature 324:585, 1987
29. Schlissel MS, Baltimore D: Activation of immunoglobulin kappa rearrangement correlates with induction of germline kappa gene transcription. Cell 58:1001, 1989
30. Ferrier P, Krippl B, Blackwell TK, Furley AJ, Suh H, Winoto A, Cook WD, Hood L, Constantini F, Alt FW: Separate elements control DJ and VDJ rearrangement in a transgenic recombination substrate. EMBO J 9:117, 1990
31. Oltz EM, Alt FW, Lin WC, Chen J, Taccioli G, Desiderio S, Rathbun G: A VDJ recombinase inducible B cell line: Role of transcriptional enhancer elements in directing VDJ recombination. Mol Cell Biol 13:6223, 1993
32. Cedar H: DNA methylation and gene activity. Cell 53:3, 1988
33. Goodhardt M, Cavelier P, Doyen N, Kallenbach S, Babinet C, Rougeon F: Methylation status of immunoglobulin kappa gene segments correlates with their recombination potential. Eur J Immunol 23:1789, 1993
34. Serwe M, Sablitzky F: FDJ recombination in B cells is impaired but not blocked by targeted deletion of the immunoglobulin heavy chain intron enhancer. EMBO J 12:2321, 1993
35. Chen J, Young F, Bottaro A, Stewart V, Smith RK, Alt FW: Mutations of the intronic IgH enhancer and its flanking sequences differentially affect accessibility of the JH locus. EMBO J 12:4635, 1993
36. Yancopoulos GD, Alt FW: Regulation of the assembly and expression of variable-region genes. Annu Rev Immunol 4:339, 1986
37. Alt FW, Yancopoulos GD, Blackwell TK, Wood C, Thomas E, Boss M, Coffman R, Rosenberg N, Tonegawa S, Baltimore D: Ordered rearrangement of immunoglobulin heavy chain variable region. EMBO J 3:1209, 1984
38. Kitamura D, Rajewsky K: Targeted disruption of μ chain membrane exon causes loss of heavy-chain allelic exclusion. Nature 356:154, 1992
39. Nussenzweig MC, Shaw AC, Sinn E, Campostorres J, Leder P: Allelic exclusion in transgenic mice carrying mutant human IgM genes. J Ex Med 167:1967, 1988
40. Bird J, Galili N, Link M, Stites D, Sklar J: Continuing rearrangement but absence of somatic hypermutation in immunoglobulin genes of human B cell precursor leukemia. J Exp Med 168:229, 1988
41. Wasserman R, Yamada M, Ito Y, Finger LR, Reichard BA, Shane S, Lange B, Rovera G: VH gene rearrangement events can modify the immunoglobulin heavy chain during progression of B-lineage acute lymphoblastic leukemia. Blood 79:223, 1992
42. Kitchingman GR: Immunoglobulin heavy chain gene VH-D junctional diversity at diagnosis in patients with acute lymphoblastic leukemia. Blood 81:775, 1993
43. Deane M, Norton JD: Immunoglobulin heavy chain gene rearrangement involving V-V region recombination. Nucleic Acids Res 18:1652, 1990
44. Shirasawa T, Miyazoe I, Hagiwara S, Kimoto H, Shigemoto K, Taniguchi M, Takemori T: Heavy chain variable (VH) region diversity generated by VH gene replacement in the progeny of a single precursor cell transformed with a temperature sensitive mutant of abelson murine leukemia virus. J Exp Med 176:1209, 1992
45. Bories JC, Cayuela JM, Loiseau P, Sigaux F: Expression of human recombination activating genes (RAG1 and RAG2) in neoplastic lymphoid cells: Correlation with cell differentiation and antigen receptor expression. Blood 78:2053, 1991
46. Ma A, Fisher P, Dildorp R, Oltz E, Rathburn G, Achacoso P, Stall A, Alt FW: Surface IgM mediated regulation of RAG gene expression in E-mu-N-myc B cell lines. EMBO J 11:2727, 1992
47. Li YS, Hayakawa K, Hardy RR: The regulated expression of B lineage associated genes during B cell differentiation in bone marrow and fetal liver. J Exp Med 178:951, 1993
48. - variants of a human mature B cell line undergoing secondary Igl rearrangements in cell culture. Eur J Immunol 23:1501, 1993
49. Haas IG, Wabl M: Immunoglobulin heavy chain binding protein. Nature 306:387, 1983
50. Rolink A, Melchers F: Molecular and cellular origins of B lymphocyte diversity. Cell 66:1081, 1991
51. Lassoued K, Nunez CA, Billips L, Kubagawa H, Monteiro RC, LeBien TW, Cooper MD: Expression of surrogate light chain receptors is restricted to a late stage in pre-B cell differentiation. Cell 73:73, 1993
52. Melchers F, Karasuyama H, Haasner D, Bauer S, Kudo A, Sakaguchi N, Jameson B, Rolink A: The surrogate light chain in B cell development. Immunol Today 14:60, 1993
53. Bossy D, Milili M, Zucman J, Thomas G, Fougereau M, Sciff C: Organization of the λ like genes that contribute to the μ-ψ light chain complex in human pre B cells. Int Immunol 3:1081, 1991
54. Pillai S, Baltimore D: The omega and iota surrogate immunoglobulin light chains. Curr Topics Microbiol Immunol 137:136, 1988
55. van Noesl CJM, van Lier RAW: Architecture of the B cell antigen receptor. Blood 82:363, 1993
56. Tang JQ, Bene MC, Faure GC: Alternative rearrangements of immunoglobulin light chain genes in human leukemia. Leukemia 5:651, 1991
57. Pauza ME, Rehmann JA, LeBien TW: Unusual patterns of immunoglobulin gene rearrangement and expression during human B cell ontogeny: Human B cells can simultaneously express cell surface κ and λ light chains. J Exp Med 170:139, 1993
58. Mombaerts P, Iacomini J, Johnson RS, Herrup K, Tonegawa S, Papaioannou VE: RAG-1-deficient mice have no mature B and T lymphocytes. Cell 68:869, 1992
59. Shinkai Y, Rathbun G, Lam KP, Oltz EM, Stewart V, Mendelsohn M, Charron J, Datta M, Young F, Stall AM: RAG-2-deficient mice lack mature lymphocytes due to an inability to initiate VDJ rearrangement. Cell 68:855, 1992
60. Shinkai Y, Koyasu S, Nakayama K, Murphy KM, Loh DY, Reinherz EL, Alt FW: Restoration of T cell development in RAG-2-deficient mice by functional TCR transgenes. Science 259:822, 1993
61. Kitamura D, Roes J, Kuhn R, Rajewsky K: A B cell deficient mouse by targeted disruption of the membrane exon of the immunoglobulin μ chain gene. Nature 350:423, 1991
62. Jakobovits A, Vergara GJ, Kennedy JL, Hales JF, McGuinness RP, Casentini B, Brenner DG, Otten GR: Analysis of homozygous mutant chimeric mice: Deletion of the immunoglobulin heavy chain joining region blocks B cell development and antibody production. Proc Natl Acad Sci USA 90:2551, 1993
63. Era T, Ogawa M, Nishikawa S, Okamoto M, Honjo T, Akagi K, Miyazaki J, Yamamura K: Differentiation of growth signal requirement of B lymphocyte precursor is directed by expression of immunoglobulin. EMBO J 10:337, 1991
64. 5 gene. Eur J Immunol 23:1284, 1993
65. Vetrie D, Vorechosky I, Sideras P, Holland J, Davies A, Flinter F, Hammarstrom L, Kinnon C, Levinsky R, Bobrow M, Smith CIE, Bentley DR: The gene involved in X-linked agammaglobulinemia is a member of the src family of protein tyrosine kinases. Nature 361:226, 1993
66. Tsukada S, Saffran DC, Rawlings DJ, Parolini O, Cutler Allen R, Klisak I, Sparkes RS, Kubagawa H, Mohandas T, Quan S, Belmont JW, Cooper MD, Conley ME, Witte O: Deficient expression of a B cell cytoplasmic tyrosine kinase in human X-linked agammaglobulinemia. Cell 72:279, 1993
67. Sanchez M, Misulovin Z, Burkhardt AL, Mahajan S, Costa T, Franke R, Bolen JB, Nussenzweig M: Signal transduction by immunoglobulin is mediated through Igα and Igβ. J Exp Med 178:1049, 1993
68. VanDyk L, Meek K: Assembly of IgH CDR3: Mechanism, regulation, and influence on antibody. Int Rev Immunol 8:123, 1992
69. Alzari PM, Lascombe MB, Poljak RJ: Three dimensional structure of antibodies. Annu Rev Immunol 6:555, 1988
70. Foote J, Winter G: Antibody framework residues affecting the conformation of the hypervariable loops. J Mol Biol 224:487, 1992
71. Chothia C, Lesk AM, Gherardi E, Tomlinson IM, Walter G, Marks JD, Llewelyn MB, Winter G: Structural repertoire of the human VH segments. J Mol Biol 227:799, 1992
72. Sanz I: Multiple mechanisms participate in the generation of diversity of human H chain CDR3 regions. J Immunol 147:1720, 1991
73. Yamada M, Wasserman R, Reichard BA, Shane S, Caton AJ, Rovera G: Preferential utilization of specific immunoglobulin heavy chain diversity and joining segments in adult human peripheral blood B lymphocytes. J Exp Med 173:395, 1991
74. Meek K: Analysis of junctional diversity during B lymphocyte development. Science 250:820, 1990
75. Wasserman R, Galili N, Ito Y, Reichard BA, Shane S, Rovera G: Predominance of fetal type DJH joining in young children with B precursor lymphoblastic leukemia as evidence for an in utero transforming event. J Exp Med 176:1577, 1992
76. Lafaille JJ, Decloux A, Bonneville M, Takagaki Y, Tonegawa S: Junctional sequences of T cell receptor γδ genes: Implications for γδ T cell lineages and for a novel intermediate of V-D-J joining. Cell 59:859, 1989
77. MacCormack WT, Tjoelker LW, Carlson LM, Petryniak B, Barth CF, Humphries EH, Thompson CB: Chicken IgL chain rearrangement involves deletion of a circular episome and addition of single non random nucleotides to both coding region segments. Cell 56:785, 1989
78. Lieber MR: The mechanism of V(D)J recombination: A balance of diversity, specificity and stability. Cell 70:873, 1992
79. Roth DB, Menetski JP, Nakajima PB, Bosma MJ, Gellert M: V(D)J recombination: Broken DNA molecules with covalently sealed (Hairpin) coding ends in SCID mouse thymocytes. Cell 70:983, 1992
80. Rajewsky K, Forster I, Cumano A: Evolutionary and somatic selection of the antibody repertoire in the mouse. Science 238:1088, 1987
81. Berek C, Milstein C: Mutation drift and repertoire shift in the maturation of the immune response. Immunol Rev 96:23, 1987
82. Wysocki L, Manser T, Gefter ML: Somatic evolution of variable region structures during an immune response. Proc Natl Acad Sci USA 83:1847, 1986
83. Kocks C, Rajewsky K: Stepwise intraclonal maturation of antibody affinity through somatic hypermutation. Proc Natl Acad Sci USA 85:8206, 1988
84. Sharon J, Gefter ML, Wysocki LJ, Margolies MN: Recurrent somatic mutations in mouse antibodies to p-azophenylarsonate increase affinity for hapten. J Immunol 142:596, 1989
85. Shlomchik MJ, Marshak-Rothstein A, Wolfowicz CB, Rothstein TL, Weigert MG: The role of clonal selection and somatic mutation in autoimmunity. Nature 328:805, 1987
86. Haire RN, Buell RD, Litman T, Ohta Y, Fu SM, Honjo T, Matsuda F, Morena M, Cairo J, Good RA, Litman GW: Diversification, not use, of the immunoglobulin VH gene repertoire is restricted in DiGeorge syndrome. J Exp Med 178:825, 1993
87. Huang C, Stewart AK, Schwartz RS, Stollar BD: Immunoglobulin heavy chain gene expression in peripheral blood B cells. J Clin Invest 89:1331, 1992
88. van Es JH, Gmelig Meyling FHJ, Logtenberg T: High frequency of somatically mutated IgM molecules in the human adult blood B cell repertoire. Eur J Immunol 22:2761, 1992
89. Andris JS, Ehrlich PH, Ostberg L, Capra JD: Probing the human antibody repertoire to exogenous antigens. J Immunol 149:4053, 1992
90. Huang C, Stollar BD: A majority of immunoglobulin H chain cDNA of normal human adult blood lymphocytes resembles cDNA for fetal Ig and natural autoantibodies. J Immunol 151:5290, 1993
91. Ikematsu H, Harindranath N, Ueki Y, Notkins AL, Casali P: Clonal analysis of a human antibody response. J Immunol 150:1325, 1993
92. Varade WS, Marin E, Kittelberger AM, Insel RA: Use of the most JH proximal human Ig H chain V region gene VH6 in the expressed immune repertoire. J Immunol 10:4985, 1993
93. Mortari F, Wang JY, Schroeder HW Jr: Human cord blood antibody repertoire. Mixed population of VH gene segments and CDR3 distribution in the expressed Cα and Cγ repertoires. J Immunol 150:1348, 1993
94. van der Stoep N, van der Linden J, Logtenberg T: Molecular evolution of the human immunoglobulin E response: High incidence of shared mutations and clonal relatedness among epsilon VH5 transcripts from three unrelated patients with atopic dermatitis. J Exp Med 177:99, 1993
95. Bye JM, Carter C, Ciu Y, Gorick BD, Songsivilai S, Winter G, Hughes-Jones NC, Marks JD: Germline variable region gene segment derivation of human monoclonal anti-Rh(D) antibodies. J Clin Invest 90:2481, 1992
96. Stewart AK, Huang C, Long AA, Stollar BD, Schwartz RS: VH-gene representation in autoantibodies reflects the normal human B-cell repertoire, Immunol Rev 128:101, 1992
97. Chen PP, Olsen NJ, Yang PM, Soto G, Olee T, Siminovitch KA, Carson DA: From human autoantibodies to the fetal antibody repertoire to B cell malignancy - Its a small world after all. Int Rev Immunol 5:239, 1990
98. Schroeder HW Jr, Hillson JL, Perlmutter RM: Early restriction of the human antibody repertoire. Science 238:791, 1987
99. Schroeder HW Jr, Wang JY: Preferential utilization of conserved immunoglobulin heavy chain variable gene segments during human fetal life. Proc Natl Acad Sci USA 37:6146, 1990
100. Raaphorst FM, Timmers E, Kenter MJ, VanTol MJ, Vossen JM, Schuurman RK: Restricted utilization of germ-line VH3 genes and short diverse third complementarity-determining regions (CDR3) in human fetal B lymphocyte immunoglobulin heavy chain rearrangements. Eur J Immunol 22:247, 1992
101. Hillson J, Oppliger IR, Sasso EH, Milner ECB, Wener MH: Emerging human B cell repertoire - Influence of developmental stage and interindividual variation. J Immunol 149:3741, 1992
102. Mortari F, Newton JA, Wang JY, Schroeder HW Jr: The human cord blood antibody repertoire. Frequent usage of the VH7 gene family. Eur J Immunol 22:241, 1992
103. Wasserman R, Ito Y, Galili N, Yamada M, Reichard BA, Shane S, Lange B, Rovera G: The pattern of joining (JH) gene usage in the human IgH chain is established predominantly at the B cell precursor stage. J Immunol 149:511, 1992
104. Deane M, Norton JD: Preferential rearrangement of developmentally regulated immunoglobulin VH1 genes in human B-lineage cells. Leukemia 5:646, 1991
105. Decker DJ, Boyle NE, Koziol JA, Klinman NR: The expression of the IgH chain repertoire in developing bone marrow B lineage cells. J Immunol 146:350, 1991
106. Braun J, Berberian L, King L, Sanz I, Govan HL III: Restricted use of fetal VH3 immunoglobulin genes by unselected B cells in the adult. J Clin Invest 89:1395, 1992
107. Stewart AK, Huang C, Stollar BD, Schwartz RS: High-frequency representation of a single VH gene in the expressed human B cell repertoire. J Ex Med 177:409, 1993
108. Huang DF, Olee T, Masuho Y, Matsumoto Y, Carson DA, Chen PP: Sequence analyses of three immunoglobulin G anti-virus antibodies reveal their utilization of autoantibody-related immunoglobulin VH genes, but not VL genes. J Clin Invest 90:2197, 1992
109. Adderson EE, Shackelford PG, Quinn A, Carroll WL: Restricted IgH chain V gene usage in the human antibody response to Hemophilus influenza type B capsular polysaccharide. J Immunol 147:1667, 1991
110. Silverman GJ, Lucas AH: Variable region diversity in human circulating antibodies specific for the capsular polysaccharide of hemophilus influenza type B. J Clin Invest 88:911, 1991
111. Berberian L, Goodglick L, Kipps TJ, Braun J: Immunoglobulin VH3 gene products: Natural ligands for HIV gp120. Science 261:1588, 1993
112. Pascual V, Capra JD: VH4-21, a human VH gene segment overrepresented in the autoimmune repertoire. Arth Rheum 35:11, 1992
113. Matthyssens G, Rabbitts RH: Structure and multiplicity of genes for the human immunoglobulin heavy chain gene segment. Proc Natl Acad Sci USA 77:6561, 1980
114. Young F, Tucker L, Rubinstein D, Guillaume T, Andre-Schwartz J, Barrett KJ, Schwartz RS, Logtenberg T: Molecular analysis of a germline-encoded idiotypic marker of pathogenic human lupus autoantibodies. J Immunol 145:2545, 1990
115. Spatz LA, Wong KK, Williams M, Desal R, Golier J, Berman JE, Alt FW, Latov N: Cloning and sequence analysis of an anti-myelin/DNA antibody from a patient with peripheral neuropathy and chronic lymphocytic leukemia. J Immunol 144:2821, 1990
116. Lampman GW, Furie B, Schwartz RS, Stollar BD, Furie BC: Amino acid sequence of a platelet binding anti DNA monoclonal antibody. Blood 74:262, 1989
117. Manheimer Lori A, Katz JB, Pillinger M, Ghossein C, Smith A, Diamond B: Molecular characteristics of antibodies bearing an anti-DNA-associated idiotype. J Exp Med 174:1639, 1991
118. Winkler TH, Fehr H, Kalden JR: Analysis of immunoglobulin variable region genes from human IgG anti-DNA antibodies. Eur J Immunol 22:1719, 1992
119. Kipps TJ, Duffy SF: Relationship of the CD5 B cell to human tonsillar lymphocytes that express autoantibody associated cross reactive idiotypes. J Clin Invest 87:2087, 1991
120. Kipps TJ, Fong S, Tomhave E, Chen PP, Goldfien RD, Carson DA: High frequency expression of a conserved kappa light chain variable region gene in chronic lymphocytic leukemia. Proc Natl Acad Sci USA 84:2916, 1987
121. Kipps TJ, Tomhave E, Chen PP, Carson DA: Autoantibody associated kappa light chain variable region gene expressed in chronic lymphocytic leukemia with little or no somatic mutation. Implications for etiology and immunotherapy. J Exp Med 167:840, 1988
122. Chen PP, Silverman GJ, Liu MF, Carson DA: Idiotypic and molecular characterization of human rheumatoid factors. Chem Immunol 48:63, 1990
123. Kipps TJ, Carson DA: Autoantibodies in chronic lymphocytic leukemia and related systemic autoimmune diseases. Blood 81:2475, 1993
124. Rassenti LZ, Pratt LF, Chen PP, Carson DA, Kipps TJ: Autoantibody-encoding kappa L chain genes frequently rearranged in lambda light chain expressing chronic lymphocytic leukemia. J Immunol 147:1060, 1991
125. Asarnow DM, Cado D, Raulet DH: Selection is not required to produce invariant T-cell receptor gamma-gene junctional sequence. Nature 362:158, 1993
126. Rubinstein DB, Symann M, Stewart AK, Guillaume T: Restriction fragment length polymorphisms and single germline coding region sequence in VH18/2 a duplicated gene encoding autoantibody. Mol Immunol 30:403, 1993
127. Chen PP, Soto G, Carson DA: The early expression of some human autoantibody-associated heavy chain variable region genes is controlled by specific regulatory elements. Scand J Immunol 31:673, 1990
128. Yancopoulos GD, Desiderio SV, Paskind M, Kearney JF, Baltimore D, Alt FW: Preferential utilization of the most JH-proximal VH gene segments in pre B cell lines. Nature 311:727, 1984
129. Schroeder HW Jr, Walter MA, Hofker MH, Ebens A, Liao LC, Cox DW, Milner EC, Perlmutter RM: Physical linkage of a human immunoglobulin heavy chain variable region gene segment to diversity and joining region elements. Proc Natl Acad Sci USA 85:8196, 1988
130. Walter MA, Surti U, Hofker MH, Cox DW: The physical organization of the human immunoglobulin heavy chain gene. EMBO J 9:3303, 1990
131. Willems vanDijk K, Milner LA, Sasso EH, Milner EC: Chromosomal organization of the heavy chain variable region gene segments comprising the human fetal antibody repertoire. Proc Natl Acad Sci USA 89:10430, 1992
132. Feeney AJ: Predominance of VH-D-JH junctions occurring at sites of short sequence homology. J Immunol 149:222, 1992
133. Gerstein RM, Lieber MR: Extent to which homology can constrain coding exon junctional diversity in V (D) J recombination. Nature 363:625, 1993
134. Medina CA, Teale JM: Restricted κ chain expression in early ontogeny: Biased utilization of Vκ exons and preferential VκJκ recombinations. J Exp Med 177:1317, 1993
135. Gu H, Kitamura D, Rajewsky K: DH reading frame bias:evolutionary selection, antigen selection or both. Immunol Today 12:420, 1991
136. Decker DJ, Boyle NE, Klinman NR: Predominance of non productive rearrangements of VH81X gene segments: Evidence a dependence of B cell clonal maturation on the structure of nascent H chains. J Immunol 147:1406, 1991
137. Komori T, Okada A, Stewart V, Alt FW: Lack of N regions in antigen receptor variable region genes of TdT deficient lymphocytes. Science 261:1171, 1993
138. Gilfillan S, Dierich A, Lemeur M, Benoist C, Mathis D: Mice lacking TdT: Mature animals with an immature lymphocyte repertoire. Science 261:1175, 1993
139. Pandey A, Tjoelker LW, Thompson CB: Restricted immunoglobulin junctional diversity in neonatal B cells. J Exp Med 177:329, 1993
140. Pascual V, Victor K, Spellerberg M, Hamblin TJ, Stevenson K, Capra JD: VH restriction among human cold agglutinins. The VH4-21 gene segment is required to encode anti-i and anti-I specificities. J Immunol 149:2337, 1992
141. Stollar BD: Autoantibodies and autoantigens: A conserved system that may shape a primary immunoglobulin gene pool. Mol Immunol 28:1399, 1991
142. Martin T, Duffy SF, Carson DA, Kipps TJ: Evidence for somatic selection of natural autoantibodies. J Exp Med 175:983, 1992
143. HVI) throughout primate evolution. J Immunol 146:2434, 1991
144. Sanz I, Kelly P, Williams C, Scholl S, Tucker P, Capra JD: The smaller human VH gene families display remarkably little polymorphism. EMBO J 8:3741, 1989
145. Fernandez C: Genetic mechanisms for dominant VH gene expression. The VHB512 gene. J Immunol 149:2328, 1992
146. Thomas-Vaslin V, Andrade L, Freitas A, Coutinho A: Clonal persistence of lymphocytes-B in normal mice is determined by variable region-dependent selection. Eur J Immunol 21:2239, 1991
147. Goodnow CC: B-cell tolerance. Curr Opin Immunol 4:703, 1992
148. Nemazee DA, Burki K: Clonal deletion of B lymphocytes in a transgenic mouse bearing anti MHC class I antibody genes. Nature 337:562, 1989
149. Okamoto M, Murakami M, Shimizu A, Ozaki S, Tsubata T, Kumagai S, Honjo T: A transgenic model of autoimmune hemolytic anemia. J Exp Med 175:71, 1992
150. Murakami M, Tsubata T, Okamoto M, Shimizu A, Kumagai S, Imura H, Honjo T: Antigen-induced apoptotic death of Ly-1 B cells responsible for autoimmune disease in transgenic mice. Nature 357:77, 1992
151. Honjo T: Seppuku and autoimmunity. Science 258:591, 1992
152. Gay D, Saunders T, Camper S, Weigert M: Receptor editing: An approach by autoreactive B cells to escape tolerance. J Exp Med 177:999, 1993
153. Radie MZ, Erikson J, Litwin S, Weigert M: B lymphocytes may escape tolerance by revising their antigen receptors. J Exp Med 177:1165, 1993
154. Tiegs SL, Russell DM, Nemazee D: Receptor editing in self-reactive bone marrow B cells. J Exp Med 177:1009, 1993
155. Pisetsky DS, Jelinek DF, McAnally LM, Reich CF, Lipsky PE: In vitro autoantibody production by normal adult and cord blood B cells. J Clin Invest 85:899, 1990
156. Souroujon M, White Scharff ME, Andre-Schwartz J, Gefter ML, Schwartz RS: Preferential autoantibody reactivity of the preimmune B cell repertoire in normal mice. J Immunol 140:4173, 1988
157. Lydyard PM, Quartey-Papafio R, Broker B, MacKenzie L, Jouqan J, Blaschek MA, Steele J, Petrou M, Collins P, Isenberg D: The antibody repertoire of early human B cells. High frequency of autoreactivity and polyreactivity. Scand J Immunol 31:33, 1990
158. Siminovitch KA, Misener V, Kwong PC, Song QL, Chen PP: A natural autoantibody is encoded by germline heavy and lambda light chain variable region genes. J Clin Invest 84:1675, 1989
159. Dersimonian H, Schwartz RS, Barrett KJ, Stellar BD: Relationship of human variable region heavy chain germline genes to genes encoding anti-DNA antibodies. J Immunol 139:2496, 1987
160. Avrameas S: Natural autoantibodies: From horror autotoxicus to gnothus seauton. Immunol Today 12:154, 1991
161. Gallagher RB, Osmond DG: To B or not to B: That is the question. Immunol Today 12:1, 1991
162. MacDonald HR: Mechanisms of immunologic tolerance. Science 246:982, 1989
163. Schwartz RH: Acquisition of immunologic self tolerance. Cell 57:1073, 1989
164. Tomonari K: Tolerance in vitro and in vivo. Immunol Rev 116:139, 1990
165. Von Boehmer H, Kisielow P: Lymphocyte lineage commitment: Instruction versus selection. Cell 73:207, 1993
166. Silberstein LE, Litwin S, Carmack CE: Relationship of variable region genes expressed by a human B cell lymphoma secreting pathologic anti-Pr2 erythrocyte autoantibodies. J Exp Med 169:1631, 1989
167. Pascual V, Victor K, Lelsz D, Spellerberg MB, Hamblin TJ, Thompson KM, Randen I, Natvig J, Capra JD, Stevenson FK: Nucleotide sequence analysis of the V regions of two IgM cold agglutinins. J Immunol 146:4385, 1991
168. Silberstein LE, Jeffries LC, Goldman J, Friedman D, Moore JS, Nowell PC, Roelcke D, Pruzanski W, Roudier J, Silverman GJ: Variable region gene analysis of pathologic human autoantibodies to the related i and I red blood cell antigens. Blood 78:2372, 1991
169. H4.21 gene segment. J Clin Invest 92:2821, 1993
170. Deane M, Norton JD: Detection of immunoglobulin gene rearrangement in B lymphoid malignancies. Br J Haematol 74:251, 1990
171. Trainor KJ, Brisco MJ, Wan JH, Neoh S, Grist S, Morley AA: Gene rearrangement in B- and T-lymphoproliferative disease detected by the polymerase chain reaction. Blood 78:192, 1991
172. McCarthy KP, Sloane JP, Wiedemann LM: Rapid method for distinguishing clonal from polyclonal B cell populations in surgical biopsy specimens. J Clin Pathol 43:429, 1990
173. Deane M, McCarthy KP, Wiedemann LM, Norton JD: An improved method for detection of B-lymphoid clonality by polymerase chain reaction. Leukemia 5:726, 1991
174. Orphanos V, Anagnostou D, Papadaki TH, Maniatis GM, Athanassiadou A: Detection of gene rearrangements in reactive lymphoid processes. Leuk Lymphoma 9:103, 1993
175. Cogne M, Mounir S, Mahdi T, Preud'homme JL, Nau F, Guglielmi P: Production of an abnormal mu chain with a shortened VHIV subgroup variable region in a Burkitt's lymphoma cell line. Mol Immunol 27:929, 1990
176. Jonsson OG, Kitchens RL, Scott FC, Smith RG: Detection of minimal residual disease in acute lymphoblastic leukemia using immunoglobulin hypervariable region specific oligonucleotide probes. Blood 76:2072, 1990
177. Deane M, Hoffbrand AV: Detection of minimal residual disease in ALL. Cancer Treat Res 64:135, 1993
178. Negrin RS, Blume KG: The use of the polymerase chain reaction for the detection of minimal residual disease. Blood 78:255, 1991
179. Billadeau D, Blackstadt M, Greipp P, Kyle RA, Oken MM, Kay N, van Ness B: Analysis of B-lymphoid malignancies using allele-specific polymerase chain reaction: A technique for sequential quantitation of residual disease. Blood 78:3021, 1991
180. Ito Y, Wasserman R, Galili N, Reichard BA, Shane S, Lange B, Rovera G: Molecular residual disease status at the end of chemotherapy fails to predict subsequent relapse in children with B-lineage acute lymphoblastic leukemia. J Clin Oncol 11:546, 1993
181. Beishuizen A, Hahlan K, Hagemeijen A, Verhoeven MJ, Hooijkaas H, Adriansen HJ, Wolvers Tettero ILM, von Wering ER, von Dongen JJM: Multiple rearranged immunoglobulin genes in childhood acute lymphoblastic leukemia of precursor B cell origin. Leukemia 5:657, 1991
182. Carter M, Neale GAM, Kitchingman GR: Characterization of immunoglobulin heavy chain genes from an acute lymphocytic leukemia with four rearrangements. Leukemia 8:668, 1991
183. Levy R, Levy S, Cleary ML, Carroll WK, Bird J, Sklar J: Somatic mutation in human B-cell tumors. Immunol Rev 96:43, 1987
184. Stiernholm N, Kuzniar B, Berinstein NL: Absence of immunoglobulin variable region hypermutation in a large cell lymphoma. Blood 80:738, 1992
185. Ralph QM, Brisco MJ, Joshua DE, Brown R, Gibson J, Morley AA: Advancement of multiple myeloma from diagnosis through plateau phase to progression does not involve a new B-cell clone: Evidence from the Ig heavy chain gene. Blood 82:202, 1993
186. Pratt LF, Rassenti L, Larrick J, Robbins B, Banks P, Kipps TJ: Immunoglobulin gene expression in small lymphocytic lymphoma with little or no somatic hypermutation. J Immunol 143:699, 1989
187. Kuppers R, Gause A, Rajewsky K: B cells of chronic lymphatic leukemia express V genes in unmutated form. Leuk Res 15:487, 1991
188. Rassenti LZ, Kipps TJ: Lack of extensive somatic mutations in the VH5 genes used in common B cell chronic lymphocytic leukemia. J Exp Med 177:1039, 1993
189. Deane M, Norton JD: Immunoglobulin heavy chain variable region family usage is independent of tumor cell phenotype in human B lineage leukemias. Eur J Immunol 20:2209, 1990
190. Yoneda N, Tatsumi E, Kawano S, Matsuo Y, Minowada J, Yamaguchi N: Human
191. Carroll WL, Yu M, Link MP, Korsmeyer SJ: Absence of Ig V region gene somatic hypermutation in advanced Burkitt's lymphoma. J Immunol 143:692, 1989
192. Cogne M, Mounir S, Preud'homme JL, Nau F, Guglielmi P: Burkitt's lymphoma cell lines producing truncated-immunoglobulin chains lacking part of the variable region. Eur J Immunol 18:1485, 1988
193. Anker R, Caldwell J, Brokaw J, Pollok BA: Characterisation of immunoglobulin mRNA expression in Burkitt lymphoma cell lines. Int J Cancer 43:930, 1989
194. Cogne M, Preud'homme JL, Guglielmi P: Immunoglobulin gene alterations in human heavy chain diseases. Res Immunol 140:487, 1989
195. Pollok BA, Anker R, Eldridge P, Hendershot L, Levitt D: Molecular basis of the cell-surface expression of immunoglobulin m chain without light chain in human B lymphocytes. Proc Natl Acad Sci USA 84:9199, 1987
196. Lenoir GM, Preud'homme JL, Bemheim A, Berger R: Correlation between immunoglobulin light chain expression and variant translocation in Burkitt's lymphoma. Nature 298:474, 1982
197. Kipps TJ, Robbins BA, Kuster P, Carson DA: Autoantibody-associated cross-reactive idiotypes expressed at high frequency in chronic lymphocytic leukemia relative to B-cell lymphomas of follicular center cell origin. Blood 72:422, 1988
198. Kipps TJ, Robbins BA, Tefferi A, Meisenholder G, Banks PM, Carson DA: CD5-positive B-cell malignancies frequently express cross-reactive idiotypes associated with IgM autoantibodies. Am J Pathol 136:809, 1990
199. Kipps TJ, Tomhave E, Pratt LF, Duffy S, Chen PP, Carson DA: Developmentally restricted VH gene expressed at high frequency in chronic lymphocytic leukemia. Proc Natl Acad Sci USA 86:5913, 1989
200. Kipps TJ, Rassenti LZ, Duffy S, Johnson T, Kobayashi R, Carson DA: Immunoglobulin V gene expression in CD5 B-cell malignancies. Ann NY Acad Sci 651:373, 1992
201. Wortis HH: Surface markers, heavy chain sequences and B cell lineages. Int Rev Immunol 8:235, 1992
202. Frieman DF, Moore JS, Erikson J, Manz J, Goldman J, Nowell PC, Silberstein LE: Variable region gene analysis of an isotype switched (IgA) variant of chronic lymphocytic leukemia. Blood 80:2287, 1992
203. Cai J, Humphries C, Richardson A, Tucker PW: Extensive and selective mutation of a rearranged VH5 gene in human B cell chronic lymphocytic leukemia. J Exp Med 176:1073, 1992
204. Ebeling SB, Schutte MEM, Logtenberg T: Molecular analysis of VH and VL regions expressed in IgG bearing chronic lymphocytic leukemia (CLL): Further evidence that CLL is a heterogeneous group of tumors. Blood 82:1626, 1993
205. Cherepakhin V, Baird SM, Meisenholder GW, Kipps TJ: Common clonal origin of chronic lymphocytic leukemia and high grade lymphoma of Richter's syndrome. Blood 82:3141, 1993
206. Miller RA, Hart S, Samoszuk M, Coulter C, Brown S, Czerwinski D, Kelkenberg J, Royston I, Levy R: Shared idiotypes expressed by human B-cell lymphomas. N Engl J Med 321:851, 1989
207. Stevenson FK, Spellerberg MB, Treasure J, Chapman CJ, Silberstein LE, Hamblin TJ, Jones DB: Differential usage of an Ig heavy chain variable region gene by human B-cell tumors. Blood 82:224, 1993
208. Bahler DW, Levy R: Clonal evolution of a follicular lymphoma: Evidence for antigen selection. Proc Natl Acad Sci USA 86:6770, 1992
209. Cleary ML, Meeker TC, Levy S, Lee E, Trela M, Sklar J, Levy R: Clustering of extensive somatic mutations in the variable region of an immunoglobulin heavy chain gene from a human B cell lymphoma. Cell 44:97, 1986
210. Levy S, Mendel E, Kon S, Avnur Z, Levy R: Mutational hot spots in Ig V region genes of human follicular lymphomas. J Exp Med 168:475, 1988
211. Friedman DF, Cho EA, Goldman J, Carmack CE, Besa EC, Hardy RR, Silberstein LE: The role of clonal selection in the pathogenesis of an autoreactive human B cell lymphoma. J Exp Med 174:525, 1991
212. Cleary M, Galili N, Trela M, Levy R, Sklar J: Single cell origin of bigenotypic and biphenotypic B cell proliferations in human follicular lymphomas. J Exp Med 167:582, 1988
213. Zelenetz AD, Chen TT, Levy R: Clonal expansion in follicular lymphoma occurs subsequent to antigenic selection. J Exp Med 176:1137, 1992
214. Carroll WL, Lowder JN, Streifer R, Warnke R, Levy S, Levy R: Idiotype variant cell populations in patients with B cell lymphoma. J Exp Med 164:1566, 1986
215. Meeker T, Lowder JN, Cleary ML, Stewart S, Warnke R, Sklar J, Levy R: Emergence of idiotype variants during therapy of B cell lymphoma with anti-idiotype antibodies. N Engl J Med 312:1658, 1985
216. Zelenetz AD, Chen TT, Levy R: Histologic transformation of follicular lymphoma to diffuse lymphoma represents tumor progression by a single malignant B cell. J Exp Med 173:197, 1991
217. Diss TC, Peng T, Wotherspoon AC, Pan L, Speight PM, Isaacson PG: A single neoplastic clone in sequential biopsy specimens from a patient with primary gastric mucosa associated lymphoid tissue lymphoma and sjogrens syndrome. N Engl J Med 329:172, 1993
218. Bakkus MH, Heirman C, VanRiet I, VanCamp B, Thielemans K: Evidence that multiple myeloma Ig heavy chain VDJ genes contain somatic mutation. Blood 80:2326, 1992
219. Berenson JR, Lichtenstein A, Hart S, Palomares, Miller RA: Expression of shared idiotypes by paraproteins from patients with multiple myeloma and monoclonal gammopathy of undetermined significance. Blood 75:2107, 1990
220. Palumbo A, Battaglio S, Astolfi M, Frieri R, Boccadoro M, Pileri A: Multiple independent immunoglobulin class-switch recombinations occurring within the same clone in myeloma. Br J Haematol 82:676, 1992
221. Billadeau D, Quam L, Thomas W, Kay N, Greipp P, Kyle R, Oken MM, van Ness B: Detection and quantitation of malignant cells in the peripheral blood of multiple myeloma patients. Blood 80:1818, 1992
222. Corradini P, Boccadoro M, Voena C, Pileri A: Evidence for a bone marrow B cell transcribing malignant plasma cell VDJ joined to a Cμ sequence in immunoglobulin (IgG)- and IgA-secreting multiple myelomas. Molecular evidence for B lymphocyte involvement in multiple myeloma. J Exp Med 178:1091, 1993
223. Billadeau D, Ahmann G, Greipp P, Van Ness B: The bone marrow of multiple myeloma patients contains B cell populations at different stages of differentiation that are clonally related to the malignant plasma cell. J Exp Med 178:1023, 1993
224. Cogne M, Preud'homme JL, Bauwens M, Touchard G, Aucouturier P: Structure of a monoclonal kappa chain of the V kappa IV subgroup in the kidney and plasma cells in light chain deposition disease. J Clin Invest 87:2186, 1991
225. Cogne M, Guglielmi P: Exon skipping without splice site mutation accounting for abnormal immunoglobulin chains in non secretory human myeloma. Eur J Immunol 23:1289, 1993